Nanjing, China

Fangliang Zhang

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Fangliang Zhang: Innovator in Antigen Binding Proteins**

Introduction

Fangliang Zhang is a noteworthy inventor based in Nanjing, China, recognized for his contributions to the field of biotechnology. With a significant focus on the development of multispecific antigen binding proteins, his innovative work is paving the way for advancements in therapeutic applications.

Latest Patents

Fangliang Zhang holds a patent for "Multispecific antigen binding proteins and methods of use thereof." This patent details multispecific, including bispecific, antigen binding proteins that consist of a first antigen binding domain featuring a heavy chain variable domain and a light chain variable domain, alongside a second antigen binding domain that comprises a single-domain antibody. Furthermore, the patent includes pharmaceutical compositions containing these multispecific antigen binding proteins, along with kits and methods for their use.

Career Highlights

Currently, Fangliang Zhang is associated with Nanjing Legend Biotech Co., Ltd., where he continues to innovate in the field of biotechnology. His research is instrumental in exploring new frontiers in antigen binding technology, contributing to significant advancements in targeted therapies.

Collaborations

Fangliang collaborates with notable colleagues such as Chuan-Chu Chou and Yafeng Zhang. Their combined expertise and dedication drive the groundbreaking research and development efforts at Nanjing Legend Biotech Co., Ltd.

Conclusion

Fangliang Zhang is an exemplar of innovation in the biotechnology sector, with his patent on multispecific antigen binding proteins representing a pivotal contribution to medical therapeutics. Through his collaborations and continued research, he is set to influence the landscape of biopharmaceutical advancements significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…